Familial Creutzfeldt-Jakob Disease Codon 200 Prion Disease in Libyan Jews

Medicine

Volumn 76, Issue 4, 1997, Pages 227-237

  Meiner, Zeev ^a,b,c   Gabizon, Ruth ^a   Prusiner, Stanley B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGE; AGED; ALLELE; CODON; COMPARATIVE STUDY; CREUTZFELDT JAKOB DISEASE; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; INCIDENCE; JEW; LIBYAN ARAB JAMAHIRIYA; MALE; MIDDLE AGED; PEDIGREE; POINT MUTATION; REVIEW; VIROLOGY;

ADULT; AGE FACTORS; AGED; ALLELES; APOLIPOPROTEINS E; CODON; CREUTZFELDT-JAKOB SYNDROME; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; INCIDENCE; JEWS; LIBYA; MALE; MIDDLE AGED; PEDIGREE; POINT MUTATION; POLYMORPHISM, GENETIC;

EID: 0031183207     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199707000-00001     Document Type: Article

References (87)

1. Alter M. Creutzfeldt-Jakob disease: Hypothesis for high incidence in Libyan Jews in Israel [letter]. Science 180: &18, 1974.
2. Alter M, Kahana E. Creutzfeldt-Jakob disease among Libyan Jews in Israel [letter]. Science 192:428, 1976.
3. Amouyel P, Vidai O, Launay JM, Laplanche JL. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 344:1315-18, 1994.
4. Anonymous. Guidelines for the molecular genetics predictive test in + Huntington's disease. International Huntington Association (IIIA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Neurology 44:1533-36, 1994.
5. Antonine JC, Laplanche JL, Mosnier JF, Beaudry P, Châtelain J, Michel D. DemyeUnating peripheral neuropathy with Creutzfeldt-Jakob disease and mutation at codon 200 of the prion protein gene. Neurology 46:1123-27, 1996.
6. Baker HE, Poulter M, Crow TJ, Frith CD, Lofthouse R, Ridley RM. Amino acid polymorphism in human prion protein and age at death in inherited prion disease [letter]. Lancet 337:1286, 1991.
7. Barker D, Schafer M, White R. Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell 36:131-38, 1984.'
8. Behar M, Sroka C, Elian M, Kott E, Korczyn A, Bornstein B, Sandbank U. Creutzfeldt-Jakob disease and its relation to pre-senile dementia. Harefuah 77:275-79, 1969.
9. Bertoni JM, Brown P, Goldfarb LG, Rubenstein R, Gajdusek DC. Familial Creutzfeldt-Jakob disease (codon 200 mutation) with supranuclear palsy. JAMA 268:2413-15, 1992.
10. Bockman JM, Kingsbury DT.McKinley MP, Bcndheim PE, PrusinerSB. Creutzfeldt-Jakob disease prion proteins in human brains. N Engl J Med 312:73-78, 1985.
11. Bockman JM, Prusiner SB, Tateishi J, Kingsbury DT. Immunoblotting of Creutzfeldt-Jakob disease prion proteins: Host species-specific epitopes. Ann Neurol 21:589-95, 1987.
12. Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt Jakob disease: Clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 20:597-C02, 1986.
13. Brown P, Coker-Vann M, Pomeroy K, Franko M, Asher DM, Gibbs CJ Jr, Gajdusek DC. Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med 314:547-51, 1986.
14. Brown P, Galvez S, Goldfarb LG, Nieto A, Cartier L, Gibbs CJ Jr, Gajdusek DC. Familial Creutzfeldt Jakob disease in Chile is associated with the codon 200 mutation of the PRNP amyloid precursor gene on chromosome 20. J Neurol Sci 112:65-67, 1992.
15. Brown P, Goldfarb LG, Gibbs CJ Jr, Gajdusek DC. The phenotypic expression of different mutations in transmissible familial CreutzfeldtJakob disease. Eur J Epidemiol 7:4G9-76, 1991.
16. Cathala F, Brown P, LeCanuet P, Gajdusek DC. High incidence of Creutzfeldt-Jakob disease in North African immigrants to France. Neurology 35:894-95, 1985.
17. Chapman J, Arlazoroff A, Goldfarb LG, Cervenakova L, Neufeld MY, Werber E, Herbert M, Brown P, Gajdusek DC, Korczyn AD. Fatal insomnia in a case of familial CreutzfeldtJakob disease with the codon 200L mutation. Neurology 46: 758-61, 1996.
18. Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD. The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 44:1683-S6, 1994.
19. Chapman J, Brown P, Goldfarb LG, Arlazoroff A, Gajdusek DC, Korczyn AD. Clinical heterogeneity and unusual presentations of CreutzfeldtJakob disease in Jewish patients with the PRNP codon 200 mutation. J Neurol Neurosurg Psychiatry 56:1109-12, 1993.
20. Chapman J, Brown P, Rabey JM, Goldfarb LG, Inzelberg R, Gibbs CJ Jr, Gajdusek DC, Korczyn AD. Transmission of spongiform encephalopathies from a familial Creutzfeldt Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutation. Neurology 42:1249-50, 1992.
21. Chapman J, Korczyn AD. Genetic and environmental factors determining the development of Creutzfeldt Jakob disease in Libyan Jews. Neuroepidemiology 10:228-31, 1991.
22. Cohen D, Krausz Y, Lossos A, Ben DE, Allan H. Brain SPECT imaging with Tc-99m ILM-PAO in Creutzfeldt Jakob disease. Clin Nucl Med 14: 808-10, 1989.
23. Cohen FE, Pan K-M, Huang Z, Baldwin M, Fletterick RJ, Prusiner SB. Structural clues to prion replication. Science 264:530-31, 1994.
24. Collinge J, Palmer MS, Campbell T, Sidle KCL, Carroll D, Harding A. Inherited prion disease (PrP lysine 200) in Britain: Two case reports. Br Med J 306:391-92, 1993.
25. ColMnge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic CreutzfeldtJakob disease. Lancet 337:1441-12, 1991.
26. Dlouhy SR, Ilsiao K, Farlow MR, Foroud T, Conneally PM, Johnson P, Prusiner SB, Hodes ME, Ghetti B. Linkage of the Indiana kindred of Gerstmann-Straussler-Scheinker disease to the prion protein gene. Nat Genet 1:64-67, 1992.
27. Gabizon R, Halimi M, Meiner Z. Genetics and biochemistry of CreutzfeldtJakob disease in Libyan Jews. Biomed Pharmacother 48:385-90, 1994.
28. Gabizon R, Kahana E, Ilsiao K, Prusiner SB, Meiner Z. Inherited prion disease in Libyan Jews. In: Prusiner SB, Collinge J, Powell J, Anderton B, eds. Prion diseases of humans and animals. London: EUis Horwood, pp 168-79, 1992.
29. Gabizon R, Rosenmann H, Meiner Z, Kahana I, Kahana E, Shugart Y, Ott J, Prusiner SB. Mutation and polymorphism of the prion protein gene in Libyan Jews with CreutzfeldtJakob disease. Am J Hum Genet 53:828-35, 1993.
30. Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB. Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nat Med 2:59-64, 1996.
31. Galvez S, Cartier L. Computed tomography findings in 15 cases of CreutzfeldtJakob disease with histological verification. J Neurol Neurosurg Psychiatry 47:1244-46, 1984.
32. Goldberg H, Alter M, Kahana E. The Libyan Jewish focus of CreutzfeldtJakob disease: A search for the mode of natural transmission. In: Prusiner SB, lladlow WJ, eds. Slow transmissible diseases of the nervous system. Vol. 1. New York: Academic Press, 195-211, 1979.
33. Goldfarb L, Korczyn A, Brown P, Chapman J, Gajdusek DC. Mutation in codon 200 of scrapie amyloid precursor gene linked to CreutzfeldtJakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 336: 637-38, 1990.
34. Lys mutation: An analysis of 45 families. Eur J Epidemiol 7:477-S6, 1991.
35. Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBIanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Wills PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Autilio-Gambetti L, Gajdusek DC, Lugaresi E, Gambetti P. Fatal familial insomnia and familial CreutzfeldtJakob disease: Disease phenotype determined by a DNA polymorphism. Science 258:806-8, 1992.
36. Goldfarb LG, Chapman J, Brown P, Cervenakova L, Gajdusek C, Korczyn AD. Apolipoprotein E genotype in human spongiform encephalopathies. Neurology 46(Suppl):A187, 1996.
37. Goldhammer Y, Bubis JJ, Sarova PI, Braham J. Subacute spongiform encephalopathy and its relation to Jakob-Creutzfeldt disease: Report on six cases. J Neurol Neurosurg Psychiatry 35:1-10, 1972.
38. Guiroy DC, Shankar SK, Gibbs CJ, Messenheimer JA, Das S, Gajdusek DC. Neuronal degeneration and neurofilament accumulation in the trigeminal ganglia in CreutzfeldtJakob disease. Ann Neurol 25:102-6, 19S9.
39. Herzberg L, Herzberg BN, Gibbs CJ Jr, Sullivan W, Amyx H, Gajdusek DC. CreutzfeldtJakob disease: Hypothesis for high incidence in Libyan Jews in Israel [letter]. Science 186:848, 1974.
40. Hirschberg HZ. The history of the Jews in North Africa. Vol 1.2nd ed. Leiden: EJ Brill, p 518, 1974.
41. Holman RC, Khan AS, Kent J, StrineTW, Schonberger LB. Epidemiology of CreutzfeldtJakob disease in the United States, 1979-1990: Analysis of national mortality data. Neuroepidemiology 14: 174-81, 1995.
42. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, TerwUliger JD, Westaway D, Ott J, Prusiner SB. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338:342-45, 19S9.
43. Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, Avrahami D, Scarlato G, Abramsky O, Prusiner SB, Gabizon R. Mutation of the prion protein in Libyan Jews with CreutzfeldtJakob disease. N Engl J Med 324:1091-97, 1991.
44. Huang Z, Gabriel J-M, Baldwin MA, Fletterick RJ, Prusiner SB, Cohen FE. Proposed three-dimensional structure for the cellular prion protein. Proc Natl Acad Sci U S A 91:7139-43, 1994.
45. Inoue I, Kitamoto T, Doh-ura K, Shii H, Goto I, Tateishi J. Japanese family with CreutzfeldtJakob disease with codon 200 point mutation of the prion protein gene. Neurology 44:299-301, 1994.
46. Kahana E, Milton A, Braham J, Sofer D. Creutzfeldt Jakob disease: Focus among Libyan Jews in Israel. Science 183:90-91, 1974.
47. Kahana E, Zilber N, Abraham M. Do CreutzfeldtJakob disease patients of Jewish Libyan origin have unique clinical features? Neurology 41:1390-92, 1991.
48. Kitamoto T, Yamaguchi K, Doh-ura K, Tateishi J. A prion protein missense variant is integrated in kuru plaque cores in patients with Gerstmann-Straussler syndrome. Neurology 41:306-10, 1991.
49. Korczyn AD. Neurologic genetic diseases of Jewish people. Biomed Pharmacother 48:391-97, 1994.
50. Korczyn AD, Chapman J, Goldfarb LG, Brown P, Gajdusek DC. A mutation in the prion protein gene in CreutzfeldtJakob disease in Jewish patients of Libyan, Greek, and Tunisian origin. Ann N Y Acad Sci 640:171-76, 1991.
51. Laplanche J-L, Delasnerie-Lauprêtre N, Brandel JP, Châtelain J, Beaudry P, Alperovitch A, Launay J-M. Molecular genetics of prion diseases in France. Neurology 44:2347-51, 1994.
52. Lathrop GM, Laluel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A 81:3443-46, 19S1.
53. Lehmann S, Harris DA. Mutant and infectious prion proteins display common biochemical properties in cultured cells. J Biol Chem 271:1633-37, 1996.
54. Lehmann S, Harris DA. Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc Natl Acad Sci 93:5610-14, 1996.
55. Lope ES, Junquera SR, Martinez AM, Berenguel AB. Acute ascending polyradiculoneuritis in a case of CreutzfeldtJakob disease. J Neurol Neurosurg Psychiatry 40:149-55, 1977.
56. Manetto V, Medori R, Cortelli P, Montagna P, Tinuper P, Baruzzi A, Rancurel G, Hauw JJ, Vanderhaeghen JJ, Mailleux P, Bugiani O, Tagliavini F, Bouras C, Rizzuto N, Lugaresi E, Gambetti P. Fatal familial insomnia: Clinical and pathological study of five new cases. Neurology 42:312-19, 1992.
57. Medori R, Tritschler 11 J, LeBlanc A, Villare F, Manetto V, Chen HY, Xue R, Leal S, Montagna P, Cortelli P, Tinuper P, Avoni P, Mochi M, Baruzzi A, Hauw JJ, Ott J, Lugaresi E, Autilio-Gambetti L, Gambetti P. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 326:444-49, 1992.
58. Meiner Z, Halimi M, Polakiewicz RD, Prusiner SB, Gabizon R. Presence of the prion protein in peripheral tissues of Libyan Jews with CreutzfeldtJakob disease. Neurology 42:1355-60, 1992.
59. Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA, Prusiner SB. Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A 83:2310-14, 1986.
60. Neufeld MY, Josiphov J, Korczyn AD. Demyelinating peripheral neuropathy in CreutzfeldtJakob disease. Muscle Nerve 15:1234-39, 1992.
61. Neugut RH, Neugut AI, Kahana E, Stem Z, Alter M. CreutzfeldtJakob disease: Familial clustering among Libyan-bom Israelis. Neurology 29:225-31, 1979.
62. Nisipeanu P, El Ad B, Korczyn AD. Spongiform encephalopathy in an Israeli bom to immigrants from Libya [letter]. Lancet 336:1990.
63. G3. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic CreutzfeldtJakob disease. Nature 352:340-42, 1991.
64. Petersen RB, Tabaton M, Berg L, Schrank B, Torack RM, Leal S, Julien J, Vital C, Deleplanque B, Pendlebury WW, Drachman D, Smith TW, Martin JJ, Oda M, Montagna P, Ott J, Autilio-Gambetti L, Lugaresi E, Gambetti P. Analysis of the prion protein gene in thalamic dementia. Neurology 42:1839-63, 1992.
65. Poulter M, Baker HF, Frith CD, Leach II, Lofthouse R, Ridley RM, Shah T, Owen F, Collinge J, Brown G, Hardy J, Mullan MJ, Harding AE, Bennett C, Doshi R, Crow TJ. Inherited prion disease with 144 base pahgene insertion. 1. Genealogical and molecular studies. Brain 115:75-85, 1992.
66. Prusiner SB. Molecular biology of prion diseases. Science 252:1515-22, 1991.
67. Prusiner SB. Molecular biology andgeneticsof neurodegenerative diseases caused by prions. Adv Virus Res 41:241-80, 1992.
68. G8. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 216:136-44, 1982.
69. Prusiner SB. Molecular biology and genetics of prion diseases. Phil Trans R Soc Lond B £13:447-63, 1994.
70. Prusiner SB, Hsiao KK. Human prion diseases. Ann Neurol 35:385-95, 1994.
71. Radhakrishnan K, Mousa EM. Creutzfeldt-Jakob disease in Benghazi, Libya. Neuroepidemiology 7:42-43, 1988.
72. 71a.Riek R, Homemann S, Wider G, Billeter M, Glockshuber R, Wuthrich K. NMR structure of the mouse prion protein domain PrP(121-231). Nature 382:180-82, 1996.
73. Roses AD, Saunders AM, Strittmatter WJ, Schmechel DE, PericakVance MA, Hyman B. Apolipoprotein E in Creutzfeldt-Jakob disease [letter]. Lancet 345:69, 1994.
74. Sadeh M, Chagnac Y, Goldhammer Y. Creutzfeldt-Jakob disease associated with peripheral neuropathy. Isr J Med Sci 26:220-22, 1990.
75. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SU, Rosi BL, GuseUa JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD. Association of apolipoprotein E allele el with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-72, 1993.
76. Schoene WC, Masters CL, Gibbs CJ Jr, Gajdusek DC, Tyler HR, Moore FD, Dammin GJ. Transmissible spongiform encephalopathy (Creutzfeldt-Jakob disease). Arch Neurol 38:473-77, 1981.
77. Serban D, Taraboulos A, DeArmond SJ, Prusiner SB. Rapid detection of Creutzfeldt Jakob disease and scrapie prion proteins. Neurology 40-110-17, 1990.
78. Shabtai H, Nisipeanu P, Chapman J, Korczyn AD. Pruritus in CreutzfeldtJakob disease. Neurology 46:940-11, 1996.
79. Spudich S, Mastrianni JA, Wrensch M, Gabizon R, Meiner Z, Kahana I, Rosenmann H, Kahana E, Prusiner SB. Complete penetrance of Creutzfeldt Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med 1:607-13, 1995.
80. Tagliavini F, Prelli F, Porro M, Rossi G, Giaccone G, Farlow MR, Dlouhy SR, Ghetti B, Bugiani O, Frangione B. Amyloid fibrils in GerstmannSträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 79:695-703, 1994.
81. Tateishi J, Kitamoto T, Doh-ura K, Sakaki Y, Steinmetz G, Tranchant C, Warter JM, Heldt N. Immunochemical, molecular genetic, and transmission studies on a case of Gerstmann-Sträussler-Scheinker syndrome. Neurology 40:1578-81, 1990.
82. Tatzeit J, Maeda N, Pekny M, Yang S-L, Betsholtz C, Eliasson C, Cayetano J, Camerino AP, DeArmond SJ, Prusiner SB. Scrapie in mice deficient for apolipoprotein E or glial fibrillary acidic protein. Neurology 47:449-53, 1996.
83. Telling GC, Scott M, Ilsiao KK, Foster D, Yang S-L, Torchia M, Sidle KCL, Collinge J, DeArmond SJ, Prusiner SB. Transmission of CreutzfeldtJakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U S A 91:9936-40, 1994.
84. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, DeArmond SJ, Prusiner SB. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83:79-90, 1995.
85. Udovitch AL, Valensi L The last Arab Jews: The communities of Jerba, Tunisia. London: Hanvood Academic Publishers, p 178, 1984.
86. Zilber N, Kahana E, Abraham MPH. The Libyan CreutzfeldtJakob disease focus in Israel: An epidemiologic evaluation. Neurology 41:1385-89, 1991.
87. Zuaretz F, Goita A, Zuriel S, Arbib G, Thayar F, eds. Yahadut Luv. Tel Aviv. The Organization of the Libyan Communities in Israel, p 425, 1960.